Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
SneezeEze is a healthcare and medical device company focused on providing innovative, drug-free solutions for the management of allergic rhinitis and hay fever. The company's primary product is a patented nasal spray that delivers a fine cellulose powder to the nasal cavity, forming a natural gel barrier that prevents allergens from contacting the nasal mucosa. This mechanical mode of action offers a safe alternative for patients seeking to avoid the side effects associated with traditional antihistamines and corticosteroids. SneezeEze has demonstrated clinical efficacy in reducing allergy symptoms and is marketed as a consumer health product globally. The company continues to explore applications for its barrier technology in respiratory health and allergen protection.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on SneezeEze.